Currently out of the existing stock ratings of Nathan Weinstein, 51 are a BUY (98.08%), 1 are a HOLD (1.92%).

Nathan Weinstein

Work Performance Price Targets & Ratings Chart

Analyst Nathan Weinstein, carries an average stock price target met ratio of 37.12% that have a potential upside of 48.72% achieved within 285 days. Previously, Nathan Weinstein worked at AEGIS.

Nathan Weinstein’s has documented 93 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ATAI, ATAI Life Sciences BV at 02-Jul-2025.

Wall Street Analyst Nathan Weinstein

Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 10/31/2019. The price target of $460 was fulfilled within 15 days with a profit of $131.6 (40.07%) receiving and performance score of 26.72.

Average potential price target upside

ATAI ATAI Life Sciences BV CDTX Cidara Therapeutics DRIO DarioHealth Corp ENVB Enveric Biosciences KTRA Kintara Therapeutics SCYX Scynexis VNRX Volitionrx Ltd IMUX Immunic MDWD Mediwound Ltd ORMP Oramed Pharmaceuticals CMMB Chemomab Therapeutics Ltd DRC ENTX Entera Bio Ltd IINN Inspira Technologies Oxy BHN Ltd ACST Acasti Pharma AVGR Avinger EVGN Evogene KIN Kindred Biosciences AMRN Amarin PLC DARE Dare Bioscience HROW Harrow Health TRVI Trevi Therapeutics STXS Stereotaxis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Mar-2026

$8

$0.65 (8.84%)

$12

1 months 19 days ago
(12-Aug-2026)

0/2 (0%)

$0.77 (10.65%)

Buy Since 19-Oct-2021

$7.5

$0.15 (2.04%)

$25

2 months 11 days ago
(20-Jul-2026)

0/14 (0%)

$0.31 (4.31%)

Buy Since 01-Sep-2021

$7.5

$0.15 (2.04%)

2 months 14 days ago
(17-Jul-2026)

1/4 (25%)

$0.28 (3.88%)

406

Buy Since 15-Feb-2026

$16

2 months 14 days ago
(17-Jul-2026)

0/3 (0%)

$11.97 (297.02%)

Buy Since 13-Jul-2021

$8

$0.65 (8.84%)

$17

2 months 15 days ago
(16-Jul-2026)

0/11 (0%)

$0.85 (11.89%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?